Cargando…

Remdesivir and COVID-19

Detalles Bibliográficos
Autores principales:	Wang, Lei-Yun, Cui, Jia-Jia, Ouyang, Qian-Ying, Zhan, Yan, Guo, Cheng-Xian, Yin, Ji-Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529377/ https://www.ncbi.nlm.nih.gov/pubmed/33010833 http://dx.doi.org/10.1016/S0140-6736(20)32019-5

Ejemplares similares

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity
por: Shen, Yue, et al.
Publicado: (2021)

Assessing the evidence on remdesivir
por: Núñez, Isaac, et al.
Publicado: (2021)

Assessing the evidence on remdesivir
por: Trøseid, Marius, et al.
Publicado: (2021)

Remdesivir-Induced Liver Injury in a COVID-Positive Newborn
por: Kaur, Manjit, et al.
Publicado: (2022)

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
por: Ader, Florence, et al.
Publicado: (2022)

Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
por: Wang, Lei-Yun, et al.
Publicado: (2021)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
por: Sanchez-Codez, Maria Isabel, et al.
Publicado: (2021)

Remdesivir for patients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2021)

Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola
por: Yan, Victoria C., et al.
Publicado: (2021)

Remdesivir for COVID-19: Why Not Dose Higher?
por: Yan, Victoria C., et al.
Publicado: (2021)

Personal protective equipment provision amongst Chinese anaesthesia departments before and after the outbreak of COVID-19
por: Du, Ying-Jie, et al.
Publicado: (2022)

To Determine the Efficacy of Remdesivir in Covid-19
por: Hameed, A., et al.
Publicado: (2022)

Remdesivir senkt COVID-19-Hospitalisierung
por: Dovjak, Peter, et al.
Publicado: (2022)

Remdesivir: From Ebola to COVID-19
por: Santoro, M. Gabriella, et al.
Publicado: (2021)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023)

Making decisions to mitigate COVID-19 with limited knowledge
por: Zhang, Weituo, et al.
Publicado: (2020)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

COVID-19 in Hematologic Malignancies: Big Challenges
por: Hu, Yongxian, et al.
Publicado: (2020)

METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer
por: Zhan, Lei, et al.
Publicado: (2023)

High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
por: Wang, Wenjing, et al.
Publicado: (2020)

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China
por: Chen, Jia-Hui, et al.
Publicado: (2015)

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
por: Zheng, Hong-Yi, et al.
Publicado: (2020)

Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose
por: Zhang, Yuemiao, et al.
Publicado: (2023)

Chinese medical personnel after the COVID-19 pandemic
por: Sun, Liyang, et al.
Publicado: (2023)

Association between Age-Related Macular Degeneration and Lens Opacity in Senior Population in Hainan Province
por: Zhang, Kai-Yan, et al.
Publicado: (2018)

Seeking clarity on retinal findings in patients with COVID-19
por: Ouyang, Pingbo, et al.
Publicado: (2020)

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)
por: Liu, Yu-Ying, et al.
Publicado: (2021)

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients
por: Ma, Yunju, et al.
Publicado: (2023)

Covid-19 in South Korea — Challenges of Subclinical Manifestations
por: Song, Joon-Young, et al.
Publicado: (2020)

Remdesivir wohl wirksam bei COVID-19
por: Diener, Hans-Christoph
Publicado: (2020)

Remdesivir bei Patienten mit COVID-19
por: Augustin, M., et al.
Publicado: (2020)

Uncertainty about the Efficacy of Remdesivir on COVID-19
por: Yoo, Jin-Hong
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9v5cc5imts5sd8g60uias417gg